Vectors Research Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vectors Research Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$5,000
+25.0%
1,0000.0%0.00%0.0%
Q2 2019$4,000
-20.0%
1,0000.0%0.00%
-33.3%
Q1 2019$5,000
+150.0%
1,0000.0%0.00%
+200.0%
Q4 2018$2,000
-33.3%
1,0000.0%0.00%
-50.0%
Q3 2018$3,0001,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders